Todd D. Maloney
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Todd D. Maloney has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Matt Sorensen
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
5 shared publications - Dwight R. Stoll
Department of Chemistry, Gustavus Adolphus College, 800 W. College Ave., St. Peter, MN 56082, USA
4 shared publications - Daniel Meston
Department of Chemistry, Gustavus Adolphus College, Saint Peter, MN 56082, USA
2 shared publications - David E. Clemmer
Department of Chemistry, The College of Arts & Science, Indiana University, Bloomington, IN 47405-7102, USA
2 shared publications Edie M. Sharon
Department of Chemistry
2 shared publications- Kathleen T. Grassmyer
Synthetic Molecule Design and Development, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, United States
2 shared publications
Latest Publications
- 31 August 2026
- Published by Elsevier in Journal of Chromatography A
- Vol. 1788, 467405
Effect of pore size on plate height for 23-mer oligonucleotides separated using fully porous particles and ion-pairing reversed-phase liquid chromatography
- 31 August 2026
- Published by Elsevier in Journal of Chromatography A
- Vol. 1788, 467405
Effect of pore size on plate height for 23-mer oligonucleotides separated using fully porous particles and ion-pairing reversed-phase liquid chromatography
- 14 May 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (20) , 15086-15093
Quantitation of Diastereomer Content in PS-Modified Synthetic Oligonucleotides using cIMS-MS
Small interfering RNAs (siRNAs) are promising therapeutics due to their sequence-specific gene silencing and ability to target disease-causing genes. However, susceptibility to nuclease degradation limits their efficiency, prompting modifications to be made to increase stability. A common modification used is phosphorothioate (PS) linkages. These modifications introduce chiral centers, and differences in chiral centers may influence efficacy. While cyclic ion mobility spectrometry-mass spectrometry (cIMS-MS) has proven effective for separating PS diastereomers, its utility for quantitative analysis is still unknown. Herein, we used CID-cIMS-MS to fragment a 22-mer siRNA (UBE) and studied five nucleotide-long fragment ions from both termini (b52– and y52–) containing PS linkages. To assess whether fragment diastereomer relative abundances reflect those of the intact oligonucleotide, 5-mer analogs (shortmers) matching the intact termini were synthesized and analyzed via nESI-cIMS-MS, ion pairing reversed phase liquid chromatography with UV detection (IPRP-LC-UV), and IPRP-LC with IMS detection (IPRP-LC-IMS-MS). Comparison of the fragment ion IMS distributions with their shortmer counterparts showed very similar characteristics, indicating these fragments could be directly compared to the shortmers. By aligning LC retention time with cIMS-MS mobility distributions, the relative abundances of the diastereomers from the fragment ions to those of the shortmers were compared. Our results demonstrate that CID-IMS-MS enables relative quantitation of the PS diastereomers, establishing a framework for PS modified oligonucleotide characterization.
- 14 May 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (20) , 15086-15093
Quantitation of Diastereomer Content in PS-Modified Synthetic Oligonucleotides using cIMS-MS
Small interfering RNAs (siRNAs) are promising therapeutics due to their sequence-specific gene silencing and ability to target disease-causing genes. However, susceptibility to nuclease degradation limits their efficiency, prompting modifications to be made to increase stability. A common modification used is phosphorothioate (PS) linkages. These modifications introduce chiral centers, and differences in chiral centers may influence efficacy. While cyclic ion mobility spectrometry-mass spectrometry (cIMS-MS) has proven effective for separating PS diastereomers, its utility for quantitative analysis is still unknown. Herein, we used CID-cIMS-MS to fragment a 22-mer siRNA (UBE) and studied five nucleotide-long fragment ions from both termini (b52– and y52–) containing PS linkages. To assess whether fragment diastereomer relative abundances reflect those of the intact oligonucleotide, 5-mer analogs (shortmers) matching the intact termini were synthesized and analyzed via nESI-cIMS-MS, ion pairing reversed phase liquid chromatography with UV detection (IPRP-LC-UV), and IPRP-LC with IMS detection (IPRP-LC-IMS-MS). Comparison of the fragment ion IMS distributions with their shortmer counterparts showed very similar characteristics, indicating these fragments could be directly compared to the shortmers. By aligning LC retention time with cIMS-MS mobility distributions, the relative abundances of the diastereomers from the fragment ions to those of the shortmers were compared. Our results demonstrate that CID-IMS-MS enables relative quantitation of the PS diastereomers, establishing a framework for PS modified oligonucleotide characterization.
- 11 March 2025
- Published by Elsevier in Journal of Chromatography A
- Vol. 1748, 465848
Corrigendum to “Evaluating orthogonality between ion-pair reversed phase, anion exchange, and hydrophilic interaction liquid chromatography for the separation of synthetic oligonucleotides” [Journal of Chromatography A 1705 (2023) 464184]
- 11 March 2025
- Published by Elsevier in Journal of Chromatography A
- Vol. 1748, 465848
Corrigendum to “Evaluating orthogonality between ion-pair reversed phase, anion exchange, and hydrophilic interaction liquid chromatography for the separation of synthetic oligonucleotides” [Journal of Chromatography A 1705 (2023) 464184]
- 30 January 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (5) , 2837-2844
sgRNA Single-Nucleotide Resolution by Ion-Pairing Reversed-Phase Chromatography
Single-stranded guide RNAs (sgRNAs) are important therapeutic modalities that facilitate selective genome editing by the CRISPR/Cas9 system. While these therapeutic modalities are synthesized through solid phase oligonucleotide synthesis similar to small interfering RNA (siRNAs) and antisense oligonucleotide (ASOs) therapeutics, their sequence length and complex secondary and tertiary structure hinder analytical characterization. The resulting current sgRNA methodologies have limited chromatographic selectivity near the FLP and limited MS compatibility. Here, we perform a systematic evaluation of chromatographic parameters to develop a highly selective ion-pairing reversed-phase chromatography separation for sgRNAs. We identify that stronger and more hydrophobic ion-pairing reagents promote the selectivity for long truncation impurities. Further, reduced flow rates and temperatures promote selectivity near the FLP. Together, this study reports the first single-nucleotide resolution chromatography method for an sgRNA modality while employing a highly MS-compatible mobile phase. This work provides further evidence that the sgRNA chromatographic selectivity is highly independent of on-column mass transfer. This methodology will enable the high-resolution characterization of sgRNA therapeutics, providing further insights into impurity profiles to facilitate toxicological studies and process development of these genetic medicines.
- 30 January 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (5) , 2837-2844
sgRNA Single-Nucleotide Resolution by Ion-Pairing Reversed-Phase Chromatography
Single-stranded guide RNAs (sgRNAs) are important therapeutic modalities that facilitate selective genome editing by the CRISPR/Cas9 system. While these therapeutic modalities are synthesized through solid phase oligonucleotide synthesis similar to small interfering RNA (siRNAs) and antisense oligonucleotide (ASOs) therapeutics, their sequence length and complex secondary and tertiary structure hinder analytical characterization. The resulting current sgRNA methodologies have limited chromatographic selectivity near the FLP and limited MS compatibility. Here, we perform a systematic evaluation of chromatographic parameters to develop a highly selective ion-pairing reversed-phase chromatography separation for sgRNAs. We identify that stronger and more hydrophobic ion-pairing reagents promote the selectivity for long truncation impurities. Further, reduced flow rates and temperatures promote selectivity near the FLP. Together, this study reports the first single-nucleotide resolution chromatography method for an sgRNA modality while employing a highly MS-compatible mobile phase. This work provides further evidence that the sgRNA chromatographic selectivity is highly independent of on-column mass transfer. This methodology will enable the high-resolution characterization of sgRNA therapeutics, providing further insights into impurity profiles to facilitate toxicological studies and process development of these genetic medicines.
- 16 January 2025
- Published by Elsevier in Journal of Chromatography A
- Vol. 1744, 465687
Does column length still matter? A case study of the effect of column length on resolution of therapeutic oligonucleotides
- 16 January 2025
- Published by Elsevier in Journal of Chromatography A
- Vol. 1744, 465687
Does column length still matter? A case study of the effect of column length on resolution of therapeutic oligonucleotides
- 9 September 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (38) , 15304-15312
Diastereomer Characterization of PS-Modified Synthetic Oligonucleotides Using Cyclic IMS-MS
Synthetic oligonucleotides have emerged as effective therapeutics that regulate gene expression to treat and prevent diseases. Oligonucleotide therapeutics are often modified with a substitution of a phosphorothioate (PS) linkage along the phosphodiester backbone to improve the drug performance and stability. The PS modification creates a mixture of diastereomer structures, increasing by a factor of 2n where n is the number of PS linkages. Despite recent draft guidances highlighting the importance of their characterization, analytical methods to measure the resulting diastereomers are currently lacking. Here, we present a method combining tandem mass spectrometry (MS) and tandem ion mobility spectrometry (IMS) using a cyclic IMS-MS instrument to study diastereomers in PS-modified oligonucleotides. This approach requires no enzymatic digestion as the intact oligonucleotides are directly injected into the MS instrument. Analogous to top-down proteomics, MS fragmentation of the intact oligonucleotide results in 3' and 5' fragment ends that have fewer diastereomers than their intact counterpart. Tandem IMS allows for mobility resolution of the diastereomers at the terminal ends. We tested four model oligonucleotides that differ in either the number of PS bonds or sequence to demonstrate the capability of this method to elucidate diastereomer structures on modified oligonucleotides.
- 9 September 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (38) , 15304-15312
Diastereomer Characterization of PS-Modified Synthetic Oligonucleotides Using Cyclic IMS-MS
Synthetic oligonucleotides have emerged as effective therapeutics that regulate gene expression to treat and prevent diseases. Oligonucleotide therapeutics are often modified with a substitution of a phosphorothioate (PS) linkage along the phosphodiester backbone to improve the drug performance and stability. The PS modification creates a mixture of diastereomer structures, increasing by a factor of 2n where n is the number of PS linkages. Despite recent draft guidances highlighting the importance of their characterization, analytical methods to measure the resulting diastereomers are currently lacking. Here, we present a method combining tandem mass spectrometry (MS) and tandem ion mobility spectrometry (IMS) using a cyclic IMS-MS instrument to study diastereomers in PS-modified oligonucleotides. This approach requires no enzymatic digestion as the intact oligonucleotides are directly injected into the MS instrument. Analogous to top-down proteomics, MS fragmentation of the intact oligonucleotide results in 3' and 5' fragment ends that have fewer diastereomers than their intact counterpart. Tandem IMS allows for mobility resolution of the diastereomers at the terminal ends. We tested four model oligonucleotides that differ in either the number of PS bonds or sequence to demonstrate the capability of this method to elucidate diastereomer structures on modified oligonucleotides.
- 1 October 2015
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 19 (10) , 1411-1417
Development of an NH4Cl-Catalyzed Ethoxy Ethyl Deprotection in Flow for the Synthesis of Merestinib
- 1 October 2015
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 19 (10) , 1411-1417
Development of an NH4Cl-Catalyzed Ethoxy Ethyl Deprotection in Flow for the Synthesis of Merestinib